Laura M. Freedman, MD

Articles by Laura M. Freedman, MD

Radiation for Chemo-Sensitization: A Phase II Trial of Cetuximab and Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma

ByVivek N. Patel, MD,Felix M. Chinea, MD,Deukwoo Kwon, PhD,Gustavo Fernandez, MD,Hanmath J Neboori, MD,Michael A. Samuels, MD,Laura M. Freedman, MD,Nagy M. Elsayad,Donald Weed, MD,Elizabeth Franzmann, MD,Chukwuemeka V. Ikpeazu, MD, PhD,Matthew C. Abramowitz, MD

This study evaluates low dose radiotherapy in combination with docetaxel and cetuximab in patients with recurrent, unresectable squamous cell carcinoma of the head and neck initially treated with definitive chemo-radiation therapy.

Latest Updated Articles



Contact Info

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

HCP Live
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us